MultiPharm Healthcare TURINABOL 100tab 25mg/tab

Description

Manufacturer: MultiPharm Healthcare

Turinabol, scientifically identified as (8R,9S,10R,13S,14S,17S)-4-chloro-17-hydroxy-10,13,17-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one, boasts unique characteristics that make it a highly sought-after option among athletes and bodybuilders alike.

Key Specifications:

• Half-Life: 16 hours
• Dosage: 30-50mg per day
• Water Retention: Low
• Hepatotoxicity: Low
• Aromatization: Average
• Active Ingredient: Chlorodehydromethyltestosteronum
• Anabolic Activity: 180% of Testosterone
• Androgenic Activity: 50% of Testosterone
• Steroid Detection Time: 250 Days

Chlorodehydromethyltestosterone finds application in addressing muscle wasting syndrome in HIV patients. Its low androgenic activity allows safe utilization by women without inducing virilization. Furthermore, at low doses, it minimally affects the hypothalamic-pituitary axis (HTPA) function.

In terms of muscle strength and mass augmentation, Turinabol is unparalleled. Notably, it curtails water retention as it does not aromatize into estrogen upon ingestion. Distinguished by its non-aromatizing property, Turinabol transforms into testosterone exclusively within the body, sparing users from the fatigue associated with water retention in muscles.

Effects:

• Increases endurance.
• Boosts strength.
• Enhances sexual activity.
• Lowers cortisol levels.

Potential Side Effects:

• Increased skin oiliness.
• Occurrence of pimples and acne.
• Diminished libido.
• Heightened aggression tendencies.

History of Turinabol: Originally developed as an undetectable doping agent, Turinabol played a pivotal role in East Germany's covert doping program. It marked the inaugural use of a steroid systematically for performance enhancement on a large scale, culminating in unprecedented success in Olympic competitions. Turinabol's swift clearance from the bloodstream facilitated its surreptitious use, enabling athletes to evade positive drug tests.

Steroid Profile: Turinabol boasts an exceptionally low androgenic rating, rendering it a safe option for both women and men aiming to minimize androgenic side effects. Furthermore, its inability to aromatize and lack of progestagenic activity mitigate estrogen-related complications. Turinabol's capacity to reduce systemic SHBG levels further enhances its appeal, maximizing the efficacy of co-administered steroids.